c-Myc is a protein encoded by the MYC gene in humans. It is a transcription factor that plays a crucial role in cell cycle progression, apoptosis, and cellular transformation. The c-Myc protein is involved in the regulation of various cellular processes, including cell growth, differentiation, and metabolism. It is known to be overexpressed in many types of cancer, making it a significant target for cancer research and therapy.
The c-Myc protein consists of several domains, each contributing to its function as a transcription factor. The 410-419 amino acid (aa) region of c-Myc is particularly important for its interaction with other proteins and its role in transcriptional regulation. This region is part of the transactivation domain, which is responsible for activating the transcription of target genes.
The Mouse Anti Human c-Myc (410-419aa) antibody is a monoclonal antibody that specifically recognizes the 410-419 amino acid region of the human c-Myc protein. This antibody is produced by immunizing mice with a recombinant human c-Myc protein containing the 410-419 amino acids. The spleen cells from these immunized mice are then fused with myeloma cells to create hybridoma cells that produce the desired antibody .
The Mouse Anti Human c-Myc (410-419aa) antibody is widely used in various research applications, including:
The c-Myc protein is a key player in cancer biology due to its role in promoting cell proliferation and inhibiting apoptosis. Overexpression of c-Myc is associated with various cancers, including breast, colon, and lung cancers. The Mouse Anti Human c-Myc (410-419aa) antibody is an essential tool for studying the mechanisms of c-Myc-driven oncogenesis and for developing potential therapeutic strategies targeting c-Myc.